Pluristem Therapeutics Inc (PSTI)

[emit]

I was wondering how they could announce the 87% on a youtube vid and not make a bigger deal out of it for us; one would think with that sort efficacy that the FDA would grant emergency use authorization, or something to get it in main stream helping people that are dying from it. Then look:

The EIB premise -
''A special focus on clinical development of PLX cells as a treatment for complications associated with
COVID-19''

What gives here? If it's doing 87% why are we at $2.40?
And why no leaks/periphy news such as what we saw early on from the expanded access programs such as this:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=156227235
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=158130628&txt2find=FDA

End 4th Q is very near and share price isn't showing promise.

emit...